Beth A. Chasen, M.D.
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Division of Diagnostic & Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, TX
Research Interests
Currently funded ongoing projects as nuclear medicine co-principal investigator include:
A Multicenter, Pivotal Phase 3 Study of Iomab-B Prior to Allogeneic Hematopoietic Cell Transplantation versus Conventional Care in Older Subjects with Active, Relapsed or Refractory Acute Myeloid Leukemia
A Multicenter Open Label Phase I/II Study to Evaluate the Safety, Tolerability, Biodistribution, and Anti-Tumor Activity of 177Lu-OPS201 with Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects with Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2
An International Multi-Centre, Open-Label Study to Evaluate Safety,Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor Positive Neuroendocrine Tumors (NETs)
Education & Training
Degree-Granting Education
| 1999 | Baylor College of Medicine, Houston, TX, USA, MD, Medicine |
| 1994 | Trinity University, San Antonio, TX, USA, BS, Biology |
Postgraduate Training
| 2002-2006 | Clinical Residency, Diagnostic and Interventional Imaging, University of Texas Health Science Center, Houston, TX |
| 2001-2002 | Clinical Residency, Nuclear Medicine, Baylor College of Medicine, Houston, TX |
| 1999-2000 | Clinical Residency, Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX |
Board Certifications
| 2007 | American Board of Nuclear Medicine |
| 2006 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Assistant Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013
Instructor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Instructor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Other Appointments/Responsibilities
Nuclear Medicine Site Director, Educational Programs in Radiation Oncology, Houston, TX, 2018 - Present
Institutional Committee Activities
Member, DI Quality Functional Committee, 2014 - Present
Member, DI Functional Clinical Operations Committee, 2013 - Present
Member, Nuclear Medicine Peer Review Committee, 2013 - Present
Representative, CCMS Nuclear Medicine, 2012 - Present
Member, Institutional Review Board (IRB) 1, 2010 - Present
Department Liaison, Women Faculty Program, 2010 - 2023
Nuclear Medicine Representative, Faculty Senate, 2010 - Present
Honors & Awards
| 2017 | Excellence in Clinical Quality Improvement, MD Anderson President's Recognition for Faculty Excellence |
| 1999 | Montague Lane Award in Clinical Skills, Baylor College of Medicine |
Selected Publications
Peer-Reviewed Articles
- Habibollahi P, Odisio BC, Gurusamy V, Kuban JD, Avritscher R, Abdelsalam ME, Chasen BA, Murthy R, Mahvash A. Temporary Reversal of Hepatoenteric Collaterals during 90Y Radioembolization Planning and Administration. Curr Oncol 29(12):9582-9592, 2022. e-Pub 2022. PMID: 36547167.
- Strosberg J, Wolin E, Chasen BA, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday T, Hendifar A, Oberg K, Sierra ML, Thevenet T, Margalet I, Ruszniewski P, Krenning E, NETTER-1 Study Group. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. J Clin Oncol 36(25):JCO2018785865, 2018. e-Pub 2018. PMID: 29878866.
- Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
- Al Feghali KA, Yeboa DN, Chasen BA, Gule MK, Johnson JM, Chung C. The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. e-Pub 2018. PMID: 30386741.
- Lu Y, Chasen BA, Macapinlac HA. Imaging Characteristics of Chemotherapy Related Adult-Onset Still Disease. Clin Nucl Med 42(12):980-982, 2017. PMID: 29076903.
- Rayamajhi SJ, Lee J, Mittal BR, Jessop AC, Chasen BA, Bhosale P. Cross sectional and nuclear medicine imaging of pancreatic insulinomas. Abdom Radiol (NY) 42(2):531-543, 2017. e-Pub 2016. PMID: 27639564.
- Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen BA, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E, NETTER-1 Trial Investigators. Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med 376(2):125-135, 2017. PMID: 28076709.
- Chism CB, Somcio R, Chasen BA, Ravizzini GC. Increased 18F-FDG Uptake Associated With Gastric Banding Surgical Mesh on PET/CT. Clin Nucl Med 41(5):410-1, 2016. PMID: 26825203.
- Oki Y, Chuang H, Chasen BA, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol 165(1):112-6, 2014. e-Pub 2014. PMID: 24386943.
- Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency. Case Rep Radiol. e-Pub 2013.
- Costelloe CM, Chuang HH, Chasen BA, Pan T, Fox PS, Bassett RL, Madewell JE. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT. J Cancer 9(4(7)):524-30, 2013. e-Pub 2013. PMID: 23983816.
- Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL, Madewell JE. Fast dixon whole-body MRI for detecting distant cancer metastasis: A preliminary clinical study. J Magn Reson Imaging 35(2):399-408, 2012. e-Pub 2011. PMID: 21990095.
- Mahvash A, Zaer N, Shaw C, Chasen BA, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-80, 2012. PMID: 22264555.
- Haygood TM, Malhotra K, Ng C, Chasen BA, McEnery KW, Chasen M. Migration of central lines from the superior vena cava to the azygous vein. Clin Radiol 67(1):49-54, 2012. e-Pub 2011. PMID: 22070939.
- Hulme KW, Rong J, Chasen BA, Chuang HH, Cody DD, Wong FC, Kappadath SC. A CT Acquisition Technique to Generate Images at Various Dose Levels for Prospective Dose Reduction Studies. AJR Am J Roentgenol 196(2):W144-51, 2011. PMID: 21257855.
- Costelloe CM, Murphy WA, Chasen BA. Musculoskeletal Pitfalls in 18F-FDG PET/CT: Pictorial Review. AJR Am J Roentgenol 193((3 Suppl)):WS1-WS13, Quiz S26-30, 2009. PMID: 19696250.
- Costelloe CM, Murphy WA, Chasen BA. Musculoskeletal Pitfalls in 18F-FDG PET/CT: Self-Assessment Module. AJR Am J Roentgenol 193((3 Suppl)):S26-30, 2009. PMID: 19696241.
- Gayed IW, Chang J, Kim EE, Nuñez R, Chasen BA, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, Jeter M, Henderson L, Erwin W, Komaki R. Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol 3(8):858-64, 2008. PMID: 18670303.
Abstracts
- Jackson J, Smith A, Swanston N, Chasen BA, Fitzgerald, Rohren E, Macapinlac HA. Bismuth shielding: A tool to reduce CT dose to female pediatric breast tissue during PET/CT acquisition, while not compromising image data. J Nucl Med, 2008.
Patient Reviews
CV information above last modified August 29, 2024